CD4 and autoimmune disease: Considering that autoimmune disease pathogenesis invariably involves the participation of CD4+ T cells, it is likely that blockade of IL-7Rα signaling will be an efficient treatment in a wide spectrum of autoimmune and inflammatory disorders.